Search for: ""MedImmune, Inc. v. Genentech, Inc." OR "549 U.S. 118"" Results 41 - 60 of 62
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Mar 2009, 4:40 pm
Genentech, Inc., 549 U.S. 118 (2007) (No. 05-608) (stating that only about 50% of applications become patents); Erik Belt, Medimmune Licensing Wars, Dispatch (Bromberg & Sunstein LLP, Boston, Mass.), Winter 2007, at 1, available at http://www.bromsun.com/media/Medimmune EB.pdf (same). [read post]
8 Jul 2011, 1:37 pm by SteinMcewen, LLP
Genentech Inc., 549 U.S. 118 (2007), which lowered the standard for bringing declaratory judgment actions. [read post]
5 Dec 2009, 1:01 am
Genentech, Inc., 549 U.S. 118, 127 (2007). [read post]
11 Jan 2012, 2:02 pm
Genentech, Inc., 549 U.S. 118, 127 (2007)). [read post]
14 Dec 2021, 9:57 am by Dennis Crouch
Genentech, Inc., 549 U.S. 118 (2007) where the Supreme Court found standing for a licensee to challenge a patent. [read post]
28 May 2010, 1:19 pm
Genentech, Inc., 549 U.S. 118, 127 (2007) (quoting Aetna Life Ins. [read post]
26 Oct 2021, 6:53 am by Unknown
Genentech, Inc., 549 U.S. 118 (2007), that petitioners who have been indisputably deterred by Myriad’s “active enforcement” of its patent rights nonetheless lack standing to challenge those patents absent evidence that they have been personally threatened with an infringement action? [read post]
20 May 2011, 3:06 pm
" 549 U.S. 118, 132 n.11 (2007); see also ABB Inc. v. [read post]
24 Feb 2022, 6:12 pm by Dennis Crouch
Genentech, Inc., 549 U.S. 118 (2007) where the Supreme Court found standing for a licensee to challenge a patent — and rejecting the Federal Circuit’s reasonable-apprehension-of-suit requirement. [read post]